Table 1.
Patient characteristics stratified by immunocompetency. Values are number (proportion) or number
|
Immunocompetent n = 35,581 |
Immunocompromised n = 5289 |
Overall n = 40,870 | |
|---|---|---|---|
| Sex | |||
| Female | 15,662 (86.4%) | 2456 (13.6%) | 18,118 |
| Male | 19,885 (87.6%) | 2823 (12.4%) | 22,708 |
| Missing | 34 (77.3%) | 10 (22.7%) | 44 |
| Ethnicity | |||
| White | 24,414 (86.1%) | 3934 (13.9%) | 28,348 |
| South Asian | 2220 (88.6%) | 285 (11.4%) | 2505 |
| Black | 909 (88.9%) | 114 (11.1%) | 1023 |
| East Asian | 181 (91.9%) | 16 (8.1%) | 197 |
| Other | 2380 (88%) | 324 (12%) | 2704 |
| Missing | 5477 (89.9%) | 616 (10.1%) | 6093 |
| Vaccination tier | |||
| Tier 2 | 9274 (88.5%) | 1209 (11.5%) | 10,483 |
| Tier 3 | 3454 (82.7%) | 725 (17.3%) | 4179 |
| Tier 4 | 3655 (66.4%) | 1848 (33.6%) | 5503 |
| Tier 5 | 2850 (90.7%) | 291 (9.3%) | 3141 |
| Tier 6 | 6241 (83.7%) | 1216 (16.3%) | 7457 |
| Tier 7 | 1632 (100%) | 0 | 1632 |
| Tier 8 | 1850 (100%) | 0 | 1850 |
| Tier 9 | 1711 (100%) | 0 | 1711 |
| Tier 10 | 4914 (100%) | 0 | 4914 |
| IMD quintile | |||
| 1 (most deprived) | 9438 (88.5%) | 1231 (11.5%) | 10,669 |
| 2 | 7353 (86.9%) | 1110 (13.1%) | 8463 |
| 3 | 6528 (87.2%) | 958 (12.8%) | 7486 |
| 4 | 6008 (86.3%) | 953 (13.7%) | 6961 |
| 5 (least deprived) | 5472 (85.6%) | 920 (14.4%) | 6392 |
| Missing | 782 (87%) | 117 (13%) | 899 |
| Comorbidities | |||
| Chronic kidney disease | 4176 (81.7%) | 937 (18.3%) | 5113 |
| Solid organ transplant | 0 | 324 (100%) | 324 |
| Chronic cardiac disease | 7905 (84.1%) | 1491 (15.9%) | 9396 |
| Chronic pulmonary disease | 4187 (75.3%) | 1374 (24.7%) | 5561 |
| Diabetes | 4692 (85.6%) | 789 (14.4%) | 5481 |
| Obesity | 5101 (86.2%) | 820 (13.8%) | 5921 |
| Chronic neurological disorder | 3106 (87.2%) | 457 (12.8%) | 3563 |
| Dementia | 2922 (89.8%) | 331 (10.2%) | 3253 |
| Vaccine failure | |||
| No information on the date of symptom onset | 75 (92.6%) | 6 (7.4%) | 81 |
| No virus immunity | 32,740 (87.6%) | 4641 (12.4%) | 37,381 |
| First dose failure | 1601 (82.5%) | 340 (17.5%) | 1941 |
| Second dose failure | 1165 (79.4%) | 302 (20.6%) | 1467 |
IMD, index of multiple deprivation.